New CEO at LINK Medical

27 January 2025

The board of LINK Medical has announced the appointment of Anders Göransson as the new chief executive (CEO) of the Norwegian contract research organization (CRO).

The company noted that Mr Göransson Anders has over 20 years of diverse experience in the life science industry, he has established an impressive track record of success. He has held prominent positions at leading biotech companies, top-tier management consulting firms, and as CEO of a publicly listed med-tech company.

Most recently, Mr Göransson served as CEO of Bactiguard AB, a global med-tech company specializing in infection prevention solutions. Prior to that, he held several international leadership roles at US biotech giant Amgen (Nasdaq: AMGN) and has also gained valuable experience at firms such as McKinsey & Company and Ernst Young.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK